Additional Benefit of Infra-low Frequency Neurofeedback in Inpatient Treatment of Anorexia Nervosa - A Sham-controlled Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00036273

Enrollment

Registered

2025-04-15

Start date

2025-05-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F50.0 F50.1

Interventions

Group 1: Interventiongroup: Patients receive TAU and additionally 20 sessions of ILF-NFB-Training Group 2: Controllgroup: Patients receive TAU and additionally 20 sessions of Sham-NFB. (Sham-NFB has a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Pat. receive psychosomatic inpatient treatment at PLK -Pat. fulfill diagnostic criteria for anorexia or atypical anorexia (according to ICD-10) -Pat. agree to participate in the study

Exclusion criteria

Exclusion criteria: -Pat. fullfill the criteria of PTSD or psychosis (according to ICD-10) or epilepsy

Design outcomes

Primary

Measure	Time frame
Changes in ED Symptoms, recorded through the Eating Disorder Examination Questionnaire (EDE-Q, Hilbert & Tuschen-Caffier,2006), data is collected at the beginning of the treatment, at the end of the treatment and 6 month after the treatment has ended.	—

Secondary

Measure	Time frame
Changes in BMI, urge to move, maladaptive regulation of emotions and depressive symptoms	—

Countries

Germany

Contacts

Public ContactHartmut Imgart

Parkland Klinik

hartmut.imgart@parkland-klinik.de05621706616

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026